PDGFRA and hepatocellular carcinoma: To address PDGFRα as a therapeutic target for HCC and to identify novel PDGFRα inhibitors with better biological function, a 2-phenyloxypyrimidine-based compound library containing 47 derivatives was synthesized and compared in the present study.